
Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure
2025-12-04 11:00:12Venus Remedies Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit limit. The share price closed at ₹770.0, marking a maximum daily loss and signalling a wave of panic selling that left a significant portion of supply unfilled in the market.
Read More
Venus Remedies Hits New 52-Week High of Rs.808.5, Marking Significant Milestone
2025-12-04 10:02:43Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally in its stock price. This milestone reflects sustained momentum driven by strong financial performance and favourable market conditions.
Read More
Venus Remedies Hits New 52-Week High of Rs.808.5, Marking Significant Milestone
2025-12-04 10:02:40Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally that has captured market attention. This milestone reflects sustained momentum supported by strong financial performance and favourable market conditions.
Read More
Venus Remedies Hits New 52-Week High at Rs.808.5 Marking Significant Milestone
2025-12-04 10:02:33Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally that reflects sustained momentum and strong market positioning over the past year.
Read More
Venus Remedies Stock Hits All-Time High at Rs.808.5 Mark
2025-12-04 09:33:45Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.808.5 today, marking a significant milestone in its market journey. This peak reflects the company’s sustained performance and notable gains over recent periods.
Read More
Venus Remedies Sees Positive Shift in Market Evaluation Amid Strong Financials
2025-12-03 11:08:25Venus Remedies has experienced a notable revision in its market evaluation, reflecting a more favourable analytical perspective driven by robust financial trends and technical signals. This shift highlights the company’s strengthening position within the Pharmaceuticals & Biotechnology sector, supported by impressive profit growth and attractive valuation metrics.
Read More
Venus Remedies Hits New 52-Week High of Rs.799.4 Marking Significant Milestone
2025-12-03 09:59:01Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.799.4 today, reflecting a strong rally and sustained momentum over recent sessions. This milestone underscores the stock’s robust performance amid a mixed market backdrop.
Read More
Venus Remedies Hits New 52-Week High of Rs.799.4, Marking Significant Milestone
2025-12-03 09:58:46Venus Remedies has reached a new 52-week high of Rs.799.4, reflecting a strong upward momentum in the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock's robust performance amid a mixed market environment, with the company demonstrating sustained gains over recent sessions.
Read More
Venus Remedies Hits New 52-Week High of Rs.799.4, Marking Significant Milestone
2025-12-03 09:58:45Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.799.4 today, reflecting a strong momentum in its stock performance amid a mixed market environment.
Read MoreVenus Remedies Limited - Other General Purpose
09-Dec-2019 | Source : NSEVenus Remedies Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Venus Remedies Limited - Updates
18-Nov-2019 | Source : NSEVenus Remedies Limited has informed the Exchange regarding 'newspaper publication of Financial results.'.
Venus Remedies Limited - Outcome of Board Meeting
13-Nov-2019 | Source : NSEVenus Remedies Limited has informed the Exchange regarding Board meeting held on November 12, 2019.
Corporate Actions
No Upcoming Board Meetings
Venus Remedies Ltd has declared 30% dividend, ex-date: 23 Sep 13
No Splits history available
No Bonus history available
No Rights history available






